Resistance looms for KRAS G12C inhibitors and rational tackling strategies

J Zhang, J Zhang, Q Liu, XX Fan, ELH Leung… - Pharmacology & …, 2022 - Elsevier
KRAS mutations are one of the most frequent activating alterations in carcinoma. Recent
efforts have witnessed a revolutionary strategy for KRAS G12C inhibitors with exhibiting …
被引用次数：30 相关文章

Resistance looms for KRAS G12C inhibitors and rational tackling strategies

J Zhang, J Zhang, Q Liu, XX Fan, ELH Leung, XJ Yao… - 2021 - repository.um.edu.mo
KRAS mutations are one of the most frequent activating alterations in carcinoma. Recent
efforts have witnessed a revolutionary strategy for KRAS G12C inhibitors with exhibiting …

Resistance looms for KRAS G12C inhibitors and rational tackling strategies

J Zhang, J Zhang, Q Liu, XX Fan, ELH Leung, XJ Yao… - 2022 - ir.lzu.edu.cn
摘要KRAS mutations are one of the most frequent activating alterations in carcinoma.
Recent efforts have witnessed a revolutionary strategy for KRAS G12C inhibitors with …

Resistance looms for KRAS G12C inhibitors and rational tackling strategies.

J Zhang, Q Liu, XX Fan, EL Leung… - Pharmacology & …, 2021 - europepmc.org
KRAS mutations are one of the most frequent activating alterations in carcinoma. Recent
efforts have witnessed a revolutionary strategy for KRAS G12C inhibitors with exhibiting …

Resistance looms for KRAS G12C inhibitors and rational tackling strategies

J Zhang, J Zhang, Q Liu, XX Fan… - Pharmacology & …, 2022 - pubmed.ncbi.nlm.nih.gov
KRAS mutations are one of the most frequent activating alterations in carcinoma. Recent
efforts have witnessed a revolutionary strategy for KRAS G12C inhibitors with exhibiting …